Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges Gharabawi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|November 2, 2005
Thyroid dysfunction during treatment with atypical antipsychoticsAndrew Greenspan, Georges Gharabawi, Joseph Kwentus
Schizophrenia Research|April 6, 2004
Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implicationsRobert A Lasser, Lian Mao, Georges Gharabawi
Journal of the American Geriatrics Society|April 17, 2004
Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementiasFred Grossman, Akiko Okamoto, Ibrahim Turkoz, et al.
International Journal of Geriatric Psychiatry|September 2, 2003
Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorderPhilip D Harvey, Judy A Napolitano, Lian Mao, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 12, 2003
International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophreniaDilip V Jeste, Yoram Barak, Subramoniam Madhusoodanan, et al.
Journal of Affective Disorders|November 24, 2004
Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorderRobert Lasser, Cynthia A Bossie, Georges Gharabawi, et al.
The Journal of Nervous and Mental Disease|December 20, 2007
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectableGeorges Gharabawi, Cynthia Bossie, Ibrahim Turkoz, et al.
International Journal of Geriatric Psychiatry|September 8, 2004
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Biological Psychiatry|January 11, 2007
Risperidone and cognitive function in children with disruptive behavior disordersGahan J Pandina, Robert Bilder, Philip D Harvey, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 1, 2006
Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trialJacobo Mintzer, Andrew Greenspan, Ivo Caers, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|November 2, 2005
Thyroid dysfunction during treatment with atypical antipsychoticsAndrew Greenspan, Georges Gharabawi, Joseph Kwentus
Schizophrenia Research|April 6, 2004
Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implicationsRobert A Lasser, Lian Mao, Georges Gharabawi
Journal of the American Geriatrics Society|April 17, 2004
Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementiasFred Grossman, Akiko Okamoto, Ibrahim Turkoz, et al.
International Journal of Geriatric Psychiatry|September 2, 2003
Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorderPhilip D Harvey, Judy A Napolitano, Lian Mao, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 12, 2003
International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophreniaDilip V Jeste, Yoram Barak, Subramoniam Madhusoodanan, et al.
Journal of Affective Disorders|November 24, 2004
Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorderRobert Lasser, Cynthia A Bossie, Georges Gharabawi, et al.
The Journal of Nervous and Mental Disease|December 20, 2007
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectableGeorges Gharabawi, Cynthia Bossie, Ibrahim Turkoz, et al.
International Journal of Geriatric Psychiatry|September 8, 2004
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Biological Psychiatry|January 11, 2007
Risperidone and cognitive function in children with disruptive behavior disordersGahan J Pandina, Robert Bilder, Philip D Harvey, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 1, 2006
Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trialJacobo Mintzer, Andrew Greenspan, Ivo Caers, et al.
Pageof 2